Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products.

IF 5.3 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Molecular Therapy Oncolytics Pub Date : 2023-11-01 DOI:10.1016/j.omto.2023.100749

Charlotte O’Brien Gore, Amy Billman, Suchete Hunjan, Jayne Colebrook, Desmond Choy, Wilson Li, Jack Haynes, Jennifer Wade, Emily Hobern, Louisa McDonald, Sophie Papa, Martijn Brugman, Shahram Kordasti, Claudia Montiel-Equihua

引用次数: 0

Abstract Image

查看原文本刊更多论文

对晚期非小细胞肺癌进行全身药物预处理可引起自体T细胞治疗产物表型的改变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Therapy Oncolytics Medicine-Oncology

CiteScore

10.90

自引率

3.50%

发文量

152

审稿时长

6 weeks

期刊介绍： Molecular Therapy — Oncolytics is an international, online-only, open access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.